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Perturbations in cellular chloride concentrations can affect cellular pH, autophagy and lead to the 
onset of apoptosis. With this in mind synthetic ion transporters have been used to disturb cellular 
ion homeostasis and thereby induce cell death; however, it is not clear whether synthetic ion 
transporters can also be used to disrupt autophagy. Here we show that squaramide-based ion 
transporters enhance the transport of chloride anions in liposomal models and promote sodium 
chloride influx into the cytosol. Liposomal and cellular transport activity of the squaramides is 
shown to correlate with cell death activity, which is attributed to caspase-dependent apoptosis. 
One ion transporter was also shown to cause additional changes in the lysosomal pH which leads 
to impairment of lysosomal enzyme activity and disruption of autophagic processes. This 
disruption is independent of the initiation of apoptosis by the ion transporter. This study provides 







Autophagy is a self-eating process that contributes to cell survival under starvation 
conditions1. During autophagy, subcellular organelles and other cell components are sequestered 
in double-membrane vesicles termed autophagosomes, and they are delivered to lysosomes for 
digestion and recycling. It is known that levels of autophagy in cancer cells are generally higher 
than those in normal cells2, leading to suggestions that autophagy-disrupting agents may be 
potentially useful in treatment of cancers3,4. 
Apoptosis or programmed cell death is an intrinsic self-killing process that is necessary for 
maintaining tissue homeostasis4. Multiple previous studies have served to demonstrate that tumor 
cells are resistant to apoptotic cell death via multiple anti-apoptotic processes5. Thus, much effort 
has been made to discover potent apoptosis inducers that can be utilized as anticancer agents6,7. 
One approach that we have explored recently involves the use of ion transporters to disrupt 
cellular ion homeostasis8. 
Normally, the extracellular chloride concentration (~120 mM) is much higher than the 
cytosolic chloride concentration (5±40 mM)9. These concentrations are maintained through the 
action of transmembrane ion transporters and channels10. It is known that the dysregulation of 
intracellular concentrations of ions, particularly chloride anions, correlates closely with the onset 
of apoptosis11. Physiological perturbations in cellular chloride concentrations can also affect pH 
and autophagy12. Lysosomal pH values are typically maintained at < 5.0 by sustaining a ca. 80 
mM lysosomal chloride concentration through the action of the lysosomal chloride transporters9. 
When the lysosomal chloride concentration is decreased to the level where the lysosomal pH 
exceeds 5.09,13, the activity of lysosomal enzymes required for the digestion of biomolecules is 
reduced leading to autophagy disruption. These observations lead us to suggest that synthetic ion 
transporters, which modulate cytosolic and lysosomal chloride concentrations and pH and 
consequently induce apoptosis and disrupt autophagy, may have a role to play as antitumor 
pharmaceuticals.  
The effect of ion transporters on autophagy has not been investigated, however several 
carrier systems have been reported that induce apoptosis. For instance, prodigiosin, a naturally 
occurring small molecule-based ion transporter, and its analogues are known to induce cancer 
cell death by altering intracellular pH gradients through HCl transport14,15,16. Recently, we found 
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that a synthetic diamide-strapped calix[4]pyrrole 1 (Fig. 1a), which promotes an influx of Cl± and 
Na+ into cells, enhances cell death via caspase-dependent apoptosis8. Interestingly, bis-(p-
nitrophenyl)ureidodecalin 2 (Fig. 1a) has been shown to function as an anion transporter without 
affecting cell viability17.  
In an effort to determine the effects of perturbing ion homeostasis on organelle and cell 
function, we have carried out a comparative study involving the known chloride transporting 
mono-squaramide 318 and a series of related mono-, bis- and tris-squaramides 4-8 (Fig. 1b). 
Tripodal squaramide systems analogous to 7 and 8 were reported to possess interesting anion 
binding properties19, while urea and thiourea analogues of 4-8 were found to be highly active 
anion transporters with cytotoxic activity20,21,22. These compounds were therefore expected to 
function as potent anion transporters with biological activity. As detailed below, several 
transporters promote apoptosis, whereas squaramide 3 additionally serves to increase the 
lysosomal pH, leading to autophagy disruption. To our knowledge, this represents the first time 
that a synthetic ion transporter has been shown to affect the function of a subcellular organelle. 
 
Results and Discussion 
 
Ion transport activity of synthetic squaramides in a liposome model. To test whether 
compounds 3-8 act as effective ion transporters, unilamellar 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) vesicles containing 489 mM NaCl with 5 mM sodium phosphate (pH 
7.2) were prepared according to standard procedures18. The vesicles were suspended in a 489 
mM external NaNO3 solution with 5 mM sodium phosphate (pH 7.2) and chloride efflux induced 
by the addition of a DMSO solution of 3-8 (1 mol% w.r.t. lipid) was monitored using a chloride 
selective electrode. As shown in Fig. 2a, compound 3 transports all of the chloride anions from 
the vesicles within ca. 120 sec, while 7 and 8 were inactive. Measurements of the initial rate of 
chloride transport (kini, Fig. 1b) revealed a transport activity order of 3 > 5 > 6 > 4 >> 7 ~ 8 (or 3 
> 5 > 4 >> 7 and 6 > 8 when the squaramides are classified in a para-CF3 and meta-CF3 series, 
respectively (Fig. 1b)). This conclusion was confirmed by concentration-dependent anion 
transport assays (Supplementary Tables S4-S7). Similar experiments, where the chloride-
containing vesicles were suspended in external Na2SO4 or NaHCO3 solutions, provided evidence 
that the squaramides are capable of Clí/NO3í transport (Fig. 2a, Fig. S49), Clí/HCO3í transport 
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(Supplementary Figs. S26 and S49) and to a lesser extent Clí/SO4í transport (Supplementary 
Figs. S32-S42 and S49). Assays using the pH-sensitive dye HPTS23,24 revealed that squaramides 
3-6 can dissipate a pH gradient, presumably through H+/Clí symport or Clí/OHí antiport 
(Supplementary Figs. S44-S47). In contrast, a 23Na NMR spectroscopic study revealed that the 
squaramides are unable to transport Na+ ions effectively across POPC bilayers at pH 7.2 
(Supplementary Figs. S33-S35). Tripodal compounds 7 and 8 were found to be inactive 
transporters. 
The poor transport ability of 7 and 8 is surprising given the potent anion transport activity of 
the corresponding urea/thiourea analogues21. Lipophilicity, which determines the ability of a 
compound to partition into the membrane, has been linked to transmembrane anion transport 
activity20,25, however, no clear correlation26 between lipophilicity and anion transport with these 
compounds could be found (Supplementary Fig. S97a). We thus sought to find a relationship 
between the anion transport and anion affinity of the squaramides. In DMSO-d6/0.5% water 
(Supplementary Table S8 and Figs. S68-S95), the bis- and tris-squaramides 5-8 displayed 1:2 
receptor-anion binding stoichiometries. This results in highly charged complexes that would be 
unable to diffuse through a non-polar lipid bilayer.  
Given the above, we calculated the most positive values of the surface electrostatic potential 
of 3-8 (Vs,max, Fig. 2b), a descriptor that has been shown to correlate strongly with hydrogen bond 
donating ability27 and anion binding20. Fig 2b shows a plot of the initial rate of transport (kini) as 
a function of Vs,max. The bell-shaped plot, with 3 at the maximum, leads us to suggest that some 
compounds interact too weakly with anions to allow efficient chloride transport (low Vs,max, 
compound 4), while others bind anions too strongly (high Vs,max, compounds 7-8). Anion 
transport requires both the uptake of the anion on one side of the membrane and release of the 
anion on the other side of the membrane. A µ*ROGLORFNV¶effect in terms of binding and transport 
has thus often been suggested for anion transporters28,29. Transporter 3 appears to embody this 
effect.  
We next sought to determine whether the receptor-mediated ion transport occurs in an 
electrogenic or electroneutral fashion. Electrogenic transport implies the net movement of a 
charged species (e.g., Clí alone), which creates a membrane potential that can be compensated 
by a separate electrogenic transport event (e.g., the transport of another anion or cation). During 
electroneutral processes no net transfer of charge occurs and the transport of the two ions (one 
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cation and one anion, or two different anions) cannot be separated. Using a recently developed 
method,30,31 and exploiting both valinomycin (an electrogenic K+ transporter)32 and monensin (an 
electroneutral M+/H+ transporter),33 we conclude that 3 is capable of both electrogenic Clí 
transport and electroneutral H+/Clí (OHí/Clí) transport (Fig. 2c and Fig. 2d). Bis-squaramides 5 
and 6 appeared to be significantly more efficient in mediating electroneutral H+/Clí (OHí/Clí) 
transport than electrogenic Clí transport (Supplementary Figs. S50 and S51). No selectivity for 
the transport of Clí over H+ (or OHí) is seen for 3, 5 or 6 (Supplementary Table S7). 
 
Cellular ion transport and cell death activities of synthetic squaramides. As a first test of 
whether the synthetic squaramides 3-8 could act as ion transporters in cells, their ability to 
promote changes in cytosolic chloride concentrations was assessed in analogy to what was done 
previously8. Briefly, Fischer rat thyroid epithelial (FRT) cells, stably expressing a mutant yellow 
fluorescent protein (YFP-F46L/H148Q/I152L) whose fluorescence is quenched sensitively by 
chloride ions, were incubated with each compound. Based on the extent of fluorescence 
quenching, the relative chloride transport activity in cells (cf. Fig. 3a and Supplementary Fig. 
S98a) was found to mirror what was found in the liposomal studies, namely 3 > 5 > 4 >> 7 for 
para-CF3 compounds and 6 > 8 for meta-CF3 compounds (Fig. 1b). Since FRT cells lack 
endogenous chloride channels/transporters, we can exclude the possibility that the chloride ion 
influx is the result of natural chloride channels/transporters. 
We then determined which cations, if any, entered the cells treated with the synthetic 
squaramides 3-8. In an initial study, changes in intracellular sodium concentrations were 
measured by treating FRT cells with the sodium fluorescent probe SBFI-AM (sodium-binding 
benzofuran isophthalate acetoxymethyl ester) followed by treatment with 3-88. It was found that 
while 3, 5 and 6 are effective in increasing the intracellular sodium concentration, compounds 4, 
7 and 8 have little or no effect (Fig. 3b and Supplementary Fig. S98b). On the basis of an 
amiloride sodium channel inhibition study8, we conclude that transporters 3, 5 and 6 function 
mainly as electrogenic chloride anion transporters and that the sodium counter ions enter cells in 
a concomitant fashion through cellular sodium channels (Figs. 3a and 3b). This is in agreement 
with what was observed in the liposome models for the coupling of 3 with valinomycin (Fig. 2d)  
In contrast to what proved true for sodium ions, the intracellular potassium and calcium 
concentrations remain unchanged upon incubation, as inferred from experiments using potassium 
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(PBFI-AM; potassium-binding benzofuran isophthalate acetoxymethyl ester) and calcium (Fluo-
4) fluorescent probes (Supplementary Fig. S99)8. Such findings are consistent with the relatively 
low extracellular concentrations of potassium (4 mM vs. 145 mM for Na+) and calcium (1.5 
mM) and the unfavourable gradients that might be expected in the case of K+ (intracellular 
concentration = 150 mM)11. These findings provide support for the notion that transporters 3, 5 
and 6 function as chloride anion transporters via channel-mediated sodium cation co-transport (cf. 
Supplementary Fig. S100).  
An increase in cytosolic chloride concentrations is known to induce cell death8,34. We thus 
investigated the effect of squaramides 3-8 on cell viability. HeLa (human cervical cancer cells) 
and A549 cells (human lung carcinoma epithelial cells) were incubated with each compound at 
various concentrations. An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay was employed to measure cell viabilities. It was found that 3, 5 and 6 with good ion 
transport activity in cells effectively induce cell death, but 4, 7 and 8 with little or no ion 
transport activity in cells display very low effect on cell death (Supplementary Fig. S101). The 
half maximum inhibitory concentration (IC50) values of 3, 5 and 6 were determined in several 
cancer cell lines (HeLa, A549, PLC/PRF/5 (hepatocellular carcinoma cells) and HepG2 
(hepatoblastoma cells)) and found to vary from 2 to 6 PM (Fig.1b and Supplementary Fig. S102).  
To examine whether the observed synthetic transporter-induced cell death results from 
increased concentrations of chloride and sodium ions in cells, the effect of extracellular Clí and 
Na+ on cell death induced by 3, 5 and 6 was determined8,35. HeLa and A549 cells were incubated 
with various concentrations of each compound in buffers containing both chloride and sodium 
ions (HEPES-buffered solutions) or in analogous buffers depleted in either chloride anions (Clí-
free solutions) or sodium cations (Na+-free solutions). As expected for an ion transport-based 
effect, the cell death activity of 3, 5 and 6 was reduced in both the Clí-free and Na+-free media 
(Supplementary Fig. S103).  
HeLa and A549 cells were also incubated with 3, 5 and 6 in the presence of various non-
toxic concentrations of amiloride. A considerable decrease in cell death activity was seen 
(Supplementary Fig. S104). This finding is consistent with the notion that the cell death mediated 





Synthetic transporters promote apoptosis. Multiple previous studies have served to show that 
dysregulation of ion homeostasis, particularly via chloride influx, can induce apoptosis8,34,36. To 
test if the present synthetic transporters accelerate apoptosis, HeLa and A549 cells were 
separately exposed to 3, 5 and 6, as well as FCCP (carbonyl cyanide 4-
(trifluoromethoxy)phenylhydrazone), a control apoptosis inducer that depolarizes mitochondrial 
membranes37. The cells were then treated with a mixture of fluorescein-labeled annexin V and 
propidium iodide (PI). The results of flow cytometry analysis showed that cells treated with 3, 5 
or 6, as well as FCCP, display positive annexin V binding and PI uptake (Fig. 3c and 
Supplementary Figs. S105a and S106a). The finding indicates that 3, 5 and 6 have apoptosis-
inducing activity. Analysis of cell size by flow cytometry revealed that cells treated with 3, 5, 6 
as well as FCCP exhibit a considerable degree of cell shrinkage (Supplementary Figs. S105b, 
S106b and S107). This finding also serves to rule out cell death via necrosis as a dominant 
mechanism because necrosis normally leads to cell swelling. The loss of mitochondrial 
membrane potential, a hallmark of apoptosis, was further investigated using a membrane 
potential sensitive probe JC-16. The results of fluorescence activated cell sorting (FACS) analysis 
revealed an increase in JC-1 green fluorescence and a decrease in red fluorescence in cells 
treated with 3, 5, 6 or FCCP, as would be expected for apoptosis (Fig. 3d and Supplementary 
Figs. S105c and S106c)38. An increase in DNA fragmentation was also observed in cells treated 
with 3, 5, 6 or FCCP (Supplementary Figs. S106d and S108). Finally, cells incubated with 3 were 
subjected to gene expression profiling analysis of mRNAs using human DNA chips. Analysis of 
DNA chip data shows that a number of positive regulators of apoptosis are upregulated by more 
than twofold compared to an untreated control, whereas expression levels of negative regulators 
of apoptosis are downregulated (Supplementary Table S10). Taken together, these results provide 
clear evidence that cells treated with synthetic transporters 3, 5 and 6 undergo apoptosis but not 
necrosis. 
 
Synthetic transporters induce caspase-dependent apoptosis. To test whether the transporters 
3, 5 and 6 induce caspase-dependent apoptosis39, HeLa and A549 cells were incubated with each 
compound at various concentrations. The caspase activities of the treated cell lysates were then 
determined by using a colorimetric peptide substrate for caspases, Ac-DEVD-pNA (pNA, p-
nitroaniline). They were found to increase in cells treated with 3, 5 or 6 (Fig. 4a and 
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Supplementary Fig. S109a). On the other hand, almost no caspase activity was seen when Ac-
DEAD-CHO, a known inhibitor of caspases, was added to the lysates of cells treated with 3, 5 or 
6. 
During caspase-dependent apoptosis, cytochrome c is released from the mitochondria into 
the cytosol where it associates with Apaf-1 to form the apoptosome40. The apoptosome complex 
activates caspase-9, which subsequently leads to caspase-3 activation through the cleavage of 
procaspase-340. In tests carried out with HeLa and A549 cells cytochrome c release into the 
cytosol and generation of cleaved caspase-3 were seen after incubation with 3, 5 or 6 (Fig. 4b 
and Supplementary Fig. S109b). Additional experiments, aimed at evaluating cleavage of a 
cellular caspase substrate, poly(ADP-ribose) polymerase (PARP), revealed that the cleaved 
product of PARP is generated in cells treated with 3, 5 or 6.  
The apoptosis inducing factor (AIF) is typically translocated into the nucleus during 
caspase-independent apoptosis41. The level of AIF in the nucleus was thus examined after 
incubating HeLa and A549 cells with 3, 5 or 6. No appreciable transport of AIF translocation into 
the nucleus was observed (Supplementary Fig. S110). These results support the conclusion that 
transporters 3, 5 and 6 promote caspase activation but not AIF-associated, caspase-independent 
apoptosis.  
To evaluate whether ion influx promoted by transporters 3, 5 and 6 is a cause or a 
consequence of apoptosis, HeLa cells were incubated with each compound at different time 
periods and then treated with the sodium fluorescent probe SBFI-AM, the Clí-quenching 
fluorescent probe MQAE (N-(ethoxycarbonylmethyl)-6-methoxy-quinolinium bromide)8,42, the 
membrane potential sensitive probe JC-1, and fluorescein±annexin V. These studies revealed that 
sodium chloride transport into cells takes place shortly after incubation with 3, 5 or 6 (Fig. 4c-d). 
However, increases in the JC-1 green fluorescence and annexin V positive cells (indicators of 
apoptosis43) occur at later times (Fig. 4e and Supplementary Fig. S111). We thus conclude that 
ion influx is the likely cause of apoptosis, rather than apoptosis leading to changes in ion flux, as 
might be expected if 3, 5 and 6 were operating via a non-transport mechanism.  
 
Synthetic transporter 3 increases the lysosomal pH and impairs lysosomal enzyme activity. 
Dysregulation of intracellular chloride concentrations can lead to suppression of cell 
proliferation via autophagy disruption by altering the lysosomal pH and impairing lysosomal 
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enzyme activity12,44. Autophagy starts with engulfment of cytoplasmic constituents by the 
phagophore, which is then expanded to form the double-membrane autophagosome 
(Supplementary Fig. S112). The autophagosome subsequently fuses with the lysosome to 
generate the autolysosome. Degradation requires lysosomal enzymes, whose activities are 
maximal at low S+S+)45. The lysosomal pH is known to be correlated with chloride anion 
concentrations, which in turn are regulated by lysosomal chloride transporters.12,46 Higher pH 
values are correlated with relatively lower lysosomal chloride anion concentrations. Since the 
lysosomal chloride concentrations are higher (ca. 80 mM) than cytosolic chloride concentrations 
(5±40 mM)9, a lysosomal membrane permeable chloride ion transporter might be expected to 
disrupt the autophagic process by promoting the transfer of chloride anions and therefore H+ out 
of the lysosome.  
To examine whether synthetic transporters 3, 5 and 6 affect the lysosomal pH, HeLa cells, 
pretreated with fluorescein-tetramethylrhodamine-tagged dextran (a ratiometric lysosomal pH 
indicator47), were separately incubated with 3, 5 and 6, along with a control 8. Treatment with 3 
leads to an increase in the lysosomal pH to ca. 7.0. In contrast, a lysosomal pH of less than 5.0 
was measured in cells treated with 5, 6 or 8 (Fig. 5a and Supplementary Figs. S113 and S114). 
Although we could not determine the lysosomal chloride concentration directly owing to the lack 
of appropriate probes, the pH-modulation results suggest that 3 decreases the lysosomal chloride 
anion concentrations under conditions where the other systems 5, 6 and 8 do not.  
Because the lysosomal pH increases when cells were treated with 3, we anticipated that this 
transporter would suppress lysosomal enzyme activities. To test this, we determined the activity 
of cathepsins B and L, which are critical enzymes that degrade proteins in lysosomes during 
autophagy, by using cell-permeable fluorogenic peptide substrates, MR-(RR)2 and MR-(FR)2, 
respectively48. The intact probes are nonfluorescent, but once the respective peptide moiety 
attached to the probes is cleaved by action of lysosomal cathepsins B and L, a red fluorescent 
dye accumulates in the cytoplasm. HeLa cells treated with 3, 5 or 6 were thus separately 
incubated with MR-(RR)2 or MR-(FR)2. As a control the cells were also treated with leupeptin, 
an inhibitor of serine and cysteine proteases, followed by incubation of MR-(RR)2 or MR-(FR)2. 
Confocal microscopy image analysis revealed that while cells treated with 5 or 6 exhibit strong 
red fluorescence signals in analogy to untreated cells, cells treated with 3 or leupeptin were 
characterized by a significantly attenuated red fluorescence (Fig. 5b). We thus conclude that 3 
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increases the lysosomal pH, leading to reduction in cathepsin B and L activity.  
 
Transporter 3 disrupts the autophagic process. Since cathepsin B and L activity was disrupted 
by 3, we anticipated that 3 (but not 5 or 6) would impair the autophagic process in cells. The 
microtubule-associated protein 1 light chain 3-II (LC3-II) and p62 are often used to monitor 
autophagy3. Typically, increased levels of LC3-II and decreased levels of p62 are observed 
during autophagy induction. In contrast, the levels of both LC3-II and p62 are increased when 
autophagic flux is disrupted. HeLa cells were thus incubated with 3, along with 5 and 6. Torin-1 
and bafilomycin A1 (BfA1) were used as controls for autophagy induction and inhibition, 
respectively. Increased levels of both LC3-II and p62 were seen in cells treated with 3 compared 
to untreated cells (Fig. 5c and Supplementary Fig. S115a). Such an increase was also observed in 
cells treated with the autophagy inhibitor BfA1. In contrast, LC3-II and p62 levels in cells 
treated with 5 and 6 were similar to those in untreated cells. As expected, cells treated with torin-
1 were characterized by an increase in the LC3-II level and a decrease in the p62 level. 
HeLa cells, stably expressing a tandem mRFP-EGFP-LC3 fusion protein (mRFP, monomeric 
red fluorescence protein; EGFP, enhanced green fluorescence protein), were also incubated with 
3, 5, 6, as well as torin-1 and BfA1. It is known that both RFP and GFP fluorescence signals are 
observed in the autophagosome. Typically, RFP but not GFP signals are seen in the acidic 
autolysosome49. Confocal microscopy image analysis of HeLa cells treated with 3 revealed a 
conspicuous increase in yellow vesicles, reflecting a merger of the GFP and RFP fluorescence 
emission signals (Fig. 5d and Supplementary Fig. S115b). This phenomenon was also observed 
in BfA1 treated cells. In contrast, cells treated with torin-1 display mainly red fluorescent 
vesicles, a finding that is indicative of autolysosome formation. Cells treated with 5 and 6 
displayed fluorescence patterns similar to those of untreated cells (Supplementary Fig. S116). On 
this basis, we conclude that autolysosomes are not being formed in cells treated with 3. Rather, 
we suggest that transporter 3 increases the lysosomal pH, disrupts lysosomal cathepsin activity in 
cells, and as a consequence impairs the autophagic process.  
Transporters 3, 5 and 6 all display good chloride ion transport activity at the lysosomal pH 
( 5.0), as inferred from liposomal studies carried out at pH 7.2 and 4.0 (Supplementary Fig. 
S48). We thus believe that the different bioactivity of these three transporters reflects the fact 
that 3 moves to the lysosome efficiently. In contrast, 5 and 6 are transported into cells but are 
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unable to leave the cell plasma membranes and reach the lysosomes due to their high 
lipophilicity (Supplementary Table S9) or their potential to bind strongly to the phospholipid 
headgroups (high Vs,max, Supplementary Table S9). This is a very specific manifestation of the 
Goldilocks effect noted above.  
 
Autophagy disruption and apoptosis induction by 3 take place via independent pathways. 
To determine whether the autophagy disruption and apoptosis induced by 3 are linked, HeLa 
cells were incubated with 3 in the absence and presence of a cell-permeable pan-caspase 
inhibitor ZVAD-FMK (benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone).50 Caspase 
activation promoted by 3 was almost completely suppressed in the presence of ZVAD-FMK 
(Supplementary Fig. S117). However, ZVAD-FMK itself has no influence on the autophagic 
process (Fig. 6a and 6b). Cells co-treated with 3 and ZVAD-FMK displayed similar levels of 
LC3-II and p62 when compared to those in cells treated with 3 alone. HeLa cells stably 
expressing mRFP-EGFP-LC3 were also treated with either 3 alone or co-treated with 3 and 
ZVAD-FMK. Similar mRFP puncta co-localized with EGFP were seen in both cases (Fig. 6b and 
supplementary Fig. S118). Further studies were carried out using BfA1. This substance is an 
inhibitor of vacuolar H+ ATPase that blocks autophagy by impairing lysosomal acidification and 
fusion of autophagosomes with lysosomes51. In contrast to 3, treatment with BfA1 alone does not 
promote caspase-dependent apoptosis. On the other hand, HeLa cells co-treated with 3 and BfA1 
undergo apoptosis to a similar degree when compared with cells treated with 3 alone (Fig. 6c-e). 
Finally, we examined the time-dependence of the apoptosis induction and autophagy disruption 
produced by 3. An increase in the levels of LC3 and p62, as well as the appearance of co-
localized puncta of mRFP with EGFP, were observed at early times after treatment of cells with 3 
(Supplementary Fig. S119) On the other hand, apoptosis promoted by 3 took place at later times 
(Fig. 4e). Collectively, the findings indicate that the autophagy disruption induced by 3 precedes 
apoptosis and occurs independently.  
 
Conclusions  
On the basis of the findings presented here we propose that transporter 3 (but not 5 or 6) 
mediates its observed autophagy impairment function by promoting chloride transport. This 
leads to an increase in lysosomal pH, which results in impairment of activity of lysosomal 
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enzymes critical for the degradation of biomolecules during autophagy. This disrupts the 
autophagic process (cf. Supplementary Fig. S120). Independent of its effect on the lysosomes, 
the increase in cytosolic sodium cations and chloride anions mediated by 3 (as well as 5 and 6) 
results in cytochrome c release from the mitochondria into the cytosol, promoting caspase-
dependent apoptosis. As a consequence, transporter 3 promotes induction of apoptosis as well as 
disrupting autophagy. We thus suggest that synthetic ion transporters, such as 3, which promote 
apoptosis and inhibit autophagy may in due course find a role as anticancer agents. 
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Figures and Figure Legends 
 
 
Figure 1. Structure of anion transporters and their activity. a, Structures of previously 
reported anion transporters 1 and 2. b, Structures of squaramide-based anion transporters 3-8 and 
the initial rate of chloride transport mediated by 1 mol% transporter from liposomes filled with a 
buffered NaCl solution and submerged in a buffered NaNO3 solution (kini), calculated Vs,max 
values and IC50 values towards HeLa cells. The inset shows the relative activity (from high to 

























Vln Mon= valinomycin = monensin
 
Figure 2. Ion transport studies using liposomal model membranes. a, Cl±/NO3± antiport 
mediated by 3-8 (added as DMSO solutions, final concentration 1 mol% w.r.t. lipid) from POPC 
vesicles loaded with 489 mM NaCl with 5 mM phosphate salts (pH 7.2) and suspended in a 489 
mM NaNO3 solution with 5 mM phosphate salts (pH 7.2). Error bars represent standard 
deviations and lines correspond to the initial rate of transport (kini) calculations. b, Plot 
representing the correlation between the initial rate of transport (kini) and Vs,max. Inset shows the 
surface electrostatic potential with Vs,max of compound 7 (colour scales ranges from blue to red, 
in kcal molí1, as follows: blue = lower than ±7.5; green = between ±7.5 and 40.0; yellow = 
between 40.0 and 87.5; and red = greater than 87.5). c, Experimental setup to determine 
electrogenic or electroneutral anion transport. POPC vesicles are loaded with 300 mM KCl with 
5 mM phosphate salts (pH 7.2) and suspended in a 300 mM potassium gluconate solution with 5 
mM phosphate salts (pH 7.2). Electrogenic K+ transport by valinomycin can only occur if it is 
balanced by electrogenic Cl± transport by 3. Electroneutral K+/H+ antiport by monensin can only 
occur if the pH gradient is dissipated by electroneutral H+/Cl± transport by 3. d, Results of the 
experiment described in c, showing both electrogenic and electroneutral anion transport by 
squaramide 3. Transporters are added as DMSO solutions to start the experiments (resulting in a 
final concentrationsof 0.1 mol% w.r.t. lipid for valinomycin and monensin, and 1 mol% w.r.t. 
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Figure 3. Synthetic transporters induce apoptosis. a, FRT cells stably transfected with a 
mutant YFP gene were incubated with various concentrations of indicated compounds for 2 
hours in the absence (grey bar) and presence (black bar) of 1 mM amiloride. The YFP 
fluorescence was then measured to examine changes in intracellular chloride ion concentrations 
(mean ± s.d., n = 3, **P < 0.001). b, FRT cells pretreated with 10 µM SBFI-AM for 1.5 hours 
were incubated with various concentrations of indicated compounds for 2 hours in the absence 
(grey bar) and presence (black bar) of 1 mM amiloride. The SBFI-AM fluorescence was then 
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measured to examine changes in intracellular sodium ion concentrations (mean ± s.d., n = 3, **P 
< 0.001). c, FlRZF\WRPHWU\RI+H/DFHOOV WUHDWHGZLWKȝ0RI LQGLFDWHGFRPSRXQGV IRU
hours and stained with fluorescein-annexin V and PI (annexin V binding versus PI uptake). 
Untreated cells are shown as a negative control. d, Flow cytometry of HeLa cells treated with 10 
ȝ0 RI LQGLFDWHG FRPSRXQGV IRU  KRXUV DQG VWDLQHG ZLWK -&-1 (red fluorescence (FL2, JC-1 
aggregate) versus green fluorescence (FL1, JC-1 monomer)). Untreated cells are shown as a 
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Figure 4. Synthetic transporters induce caspase-dependent apoptosis. a, Caspase activities of 
lysates of HeLa cells treated with the indicated compounds for 18 hours were measured by using 
 ȝ0 DFHW\O-DEVD-pNA in the absence (grey bar) and SUHVHQFH EODFN EDU RI  ȝ0 $F-
DEVD-CHO (mean ± s.d., n = 3). b, HeLa cells were treated with the indicated compounds for 
18 hours. Immunoblotting was conducted using the corresponding antibodies. E-Actin was used 
as a loading control. c, +H/DFHOOVSUHWUHDWHGZLWKȝ06%),-$0ZHUHLQFXEDWHGZLWKȝ0
of the indicated compounds for the indicated times. The SBFI-AM fluorescence was then 
measured to probe changes in the intracellular sodium ion concentration (mean ± s.d., n = 3). d, 
+H/D FHOOV SUHWUHDWHG ZLWK  P0 04$( IRU  KRXU ZHUH LQFXEDWHG ZLWK  ȝ0 RI each 
compound for the indicated times. The MQAE fluorescence was then measured to determine 
changes in the intracellular chloride ion concentration (mean ± s.d., n = 3). e, Flow cytometry of 








































Figure 5. Effect of synthetic transporters on autophagy. a, HeLa cells pretreated with 
fluorescein-tetramethylrhodamine-WDJJHG GH[WUDQ IRU  KRXUV ZHUH LQFXEDWHG ZLWK  ȝ0 RI
indicated compounds for 12 hours. The lysosomal pHs were calculated by using a pH titration 
curve shown in Fig. S109. b, HeLa cells pretreated with 3 (4 PM), 5 (4 PM), 6 (4 PM) or 
leupeptin (5 PM) for 6 hours were incubated with MR-(RR)2 or MR-(FR)2 for 4 hours. Cell 
images were obtained using confocal fluorescence microscopy (scale bar = 20 Pm). c, HeLa cells 
were treated with 3 (4 PM), 5 (4 PM), 6 (4 PM), torin-1 (1 PM) or BfA1 (5 nM) for 24 hours. 
Expression levels of LC3 and p62 were examined using western blots. Torin-1 and BfA1 were 
used as controls for autophagy induction and inhibition, respectively. d, HeLa cells stably 
expressing mRFP-EGFP-LC3 were treated with 3 (4 PM), torin-1 (1 PM) or BfA1 (5 nM) for 24 
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Figure 6. Effect of apoptosis induction promoted by 3 is independent of its ability to disrupt 
autophagy. a, HeLa cells were treated for 12 hours with 10 PM 3 in the absence and presence of 
 ȝ0 =9$'-FMK. The indicated proteins were immunoblotted using the corresponding 
DQWLERGLHV µ8Q¶ LQGLFDWHVQR WUHDWPHQWRIFHOOVZLWK3. b, HeLa cells stably expressing mRFP-
EGFP-/& ZHUH WUHDWHG IRU  KRXUV ZLWK  ȝ0 3 LQ WKH DEVHQFH DQG SUHVHQFH RI  ȝ0
ZVAD-FMK. Cell images of EGFP and mRFP, obtained using confocal fluorsecence microscopy, 
ZHUHPHUJHGVFDOHEDU ȝP µ8Q¶LQGLFDWHVQRWUHDWPHQWRIFHOOVZLWK3. c, Flow cytometry 
RI+H/DFHOOVWUHDWHGZLWKȝ03 or/and 5 nM BfA1 for 12 hours and then stained with (left) 
JC-1 or (right) fluorescein-DQQH[LQ 9 µ8Qtreated¶ LQGLFDWHV QR WUHDWPHQW RI FHOOV ZLWK 3 and 
BfA1. d, &DVSDVHDFWLYLWLHVRIO\VDWHVRI+H/DFHOOVWUHDWHGZLWKȝ03 or/and 5 nM BfA1 for 
 KRXUV ZHUH PHDVXUHG E\ XVLQJ  ȝ0 DFHW\O-DEVD-pNA in the absence (grey bar) and 
SUHVHQFHEODFNEDURIȝ0$F-DEVD-&+2PHDQVGQ µ8Q¶LQGLFDWHVQRWUHDWPHQW
of cells with 3 and BfA1. e, +H/DFHOOVZHUH WUHDWHGZLWKȝ03 or/and 5 nM BfA1 for 12 
hours. The indicated proteins were then immunoblotted by using the corresponding antibodies. 





Table of contents summary 
 
In this paper we show that a squaramide-based anion transporter can cause changes in the 
lysosomal pH which leads to impairment of lysosomal enzyme activity and disruption of 
autophagic processes. This study provides the first experimental evidence that synthetic ion 
transporters can disrupt both autophagy and induce apoptosis. 
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